.:: TuttoCongressi ::.

Hai dimenticato la password? | Registrati

E-mail

Password

Resta Collegato

Cerca per parole nell'archivio:

In archivio:

N° Relazioni: 478
N° Accessi Relaz.: 168936

III° CONGRESSO ICAR 2011- Italian Conference on AIDS and Retroviruses.... -

Palazzo Congressi e Palazzo Affari (FI)
27/03/2011 - 29/03/2011

	Programma Evento
	Info

Mostra tutti | Mostra contenuti EasyRec

27/03/11

AUDITORIUM

13:30 - 16:30
PRE-CONFERENCE ADVANCED COURSES - ADVANCED DIAGNOSTIC

Ceccherini
Introduzione

Sarmati L.
RELIABILITY AND UTILITY OF ULTRASENSITIVE VIRAL LOAD QUANTIFICATION IN CLINICAL PRACTICE - Importance of ultrasensitive viral load quantification in clinical practice

Canducci F.
RELIABILITY AND UTILITY OF ULTRASENSITIVE VIRAL LOAD QUANTIFICATION IN CLINICAL PRACTICE - Comparative technology and reliability of ultrasensitive methods

Sarmati L.
PROVIRAL DNA: TECHNOLOGY AND CLINICAL PRACTICE AT DEBATE - Clinical importance of proviral DNA assessment

Magnani M.
PROVIRAL DNA: TECHNOLOGY AND CLINICAL PRACTICE AT DEBATE - Quantification of all different viral DNA forms

Bon I.
PROVIRAL DNA: TECHNOLOGY AND CLINICAL PRACTICE AT DEBATE - Viral tropism based on DNA samples

Rusconi S.
ULTRA-DEEP SEQUENCING DEVELOPMENT AND UTILITY IN CLINICAL PRACTICE - Clinical importance of ultra-deep sequencing

Capobianchi M.R.
ULTRA-DEEP SEQUENCING DEVELOPMENT AND UTILITY IN CLINICAL PRACTICE - Comparative methods: ultra-deep sequencing or allele specific PCR?

Petrosillo N.
CLINICAL IMPLICATIONS OF HIV-1 NEF PROTEIN MUTATIONS - Clinical role of nef protein mutations

Baldanti F.
RAPID DIAGNOSIS OF HIV INFECTION - HIV rapid test? Reliability and utility

SALA-ONICE

13:30 - 16:30
PRE-CONFERENCE ADVANCED COURSES - WOMEN AND HIV: IDENTIFICATION AND MANAGEMENT OF PECULIARITIES OF HIV INFECTED WOMEN

Liuzzi G.
Females susceptibility to HIV infection

Zuccati G.
Sexually transmitted diseases and female population

Mussini C.
Screening of co-morbidities in HIV infected women

Gervasoni C.
Management of toxicity to ART in HIV infected women

Calcagno A.
Distribution and metabolism of drugs and antiretrovirals in women

Bini T.
Fertility and pregnancy in HIV infected women: an integrated approach - The infectious diseases clinician

Ravizza M.
Fertility and pregnancy in HIV infected women: an integrated approach - The gynecology specialist

Ammassari A.
HIV infection and females believes

D'Arminio Monforte A.
Women and HIV: clinical trials and cohort data

SALA-VERDE

13:30 - 16:30
PRE-CONFERENCE ADVANCED COURSES - HIV-HEPATITIS VIRUS CO-INFECTION

Cacopardo B.
Introduction: overview on epidemiology

Svicher V.
Update on pathogenesis of HIV-hepatitis co-infection

Antonucci F.
Clinical choices for treatment and follow up - HBV co-infection

Nasta P.
Clinical choices for treatment and follow up - HCV co-infection

Santantonio T.
Diagnostic tools for the staging of the disease: Laboratory in the definition of the viral framework and fibrosis

Caremani M.
Diagnostic tools for the staging of the disease: Ultrasound based diagnosis

Bruno R.
Therapy for coinfected patients

Grossi P.
Liver transplantation in coinfected patients

28/03/11

AUDITORIUM

08:30 - 09:45
LECTURES

Antonelli G.
ADVANCED UNDERSTANDING OF HIV VIROLOGY AND VIROLOGICAL MONITORING OF THE INFECTION; BUT THERE REMAIN OUTSTANDING ISSUES

Levy J.
HIV/AIDS: THE IMPORTANCE OF INNATE IMMUNITY

09:45 - 11:15
ORAL COMMUNICATIONS - SESSION I - VIROLOGY

Clementi M.
INTRODUCTION

Santoro M.M.
THE LOWEST X4 GENO2 PHENO-FALSE POSITIVE RATE IS ASSOCIATED WITH GREATER CD4 DEPLETION

Berzi A.
A GLYCOMIMETIC COMPOUND INHIBITS DC-SIGN MEDIATED HIV INFECTION IN CELLULAR AND CERVICAL EXPLANT MODELS Scheda Relatore

Poli G.
SELECTIVE UPREGULATION OF DC-SIGN IN M2A POLARIZED MACROPHAGES FACILITATES IN VITRO HIV-1 INFECTION AND TRASMISSION

Buonomini A.R.
A STUDY OF HIV CORECEPTOR TROPISM IN PAIRED PLASMA, PBMC AND CEREBROSPINAL FLUID ISOLATES FROM NAÏVE SUBJECTS

Paolucci S.
ACCUMULATION OF DEFECTIVE HI-1 VARIANTS IN A SUBTYPE SLOW-PROGRESSOR WITH HIGH RT SPECIFIC CD8+ MEMORY T-CELL RESPONSE

Michienzi A.
THE ADAR EDITING ENZYMES ARE NOVEL HIV-1 PROVIRAL FACTORS

11:30 - 12:00
LECTURE

Van Lunzen J.
CLINICAL IMMUNOLOGY OF HIV INFECTION

12:00 - 13:30
ORAL COMMUNICATIONS - SESSION III - IMMUNOLOGY

De Luca C.
TLR4 RESPONSIVENESS TO LPS STIMULATION IS UPREGULATED IN HIV-EXPOSED UNINFECTED INDIVIDUALS

Casoli C.
IN VITRO EXPOSURE OF HEALTHY CD4+ T LYMPHOCYTES TO GP120 INDUCES CHANGES IN MIRNA EXPRESSION PROFILES

Cossarizza A.
MITOCHONDRIAL DNA SUSTAINS INFLAMMATION DURING HIV INFECTION: IMPLICATIONS FOR THE TREATMENT OF THE DISEASE

De Re V.
COMPARATIVE PROTEOMIC ANALYSIS OF DLBCL FROM HIV+ AND HIV- INDIVIDUALS BY 2D DIFFERENTIAL GEL ELECTROPHORESIS

Galli M.
IL-7 RECEPTOR AND IL-15 RECEPTOR SINGLE NUCLEOTIDE POLYMORPHISMS INFLUENCE HIV-1 DISEASE PROGRESSION

Gianotti N.
PROVIRAL HIV CHANGES CORRELATE WITH CD4+CD45RA+ T-CELL RECOVERY IN PATIENTS RECEIVING RALTEGRAVIR-INCLUDING REGIMENS

15:00 - 16:30
ORAL COMMUNICATIONS - SESSION V - CLINICAL MEDICINE AND DIAGNOSIS I

Zazzi M.
INTRODUCTION

Bernardini C.
HAART, LOW LEVEL RESIDUAL VIREMIA AND RISK OF VIROLOGICAL FAILURE

Marocco R.
USEFULNESS OF QUANTITATIVE ULTRASONOGRAPHY (QUS) FOR BONE HEALTH ASSESSMENT IN HIV-INFECTED PATIENTS

Calcagno A.
TENOFOVIR AND EMTRICITABINE CSF-TO-PLASMA RATIOS CORRELATE TO THE EXTENT OF BLOOD-BRAIN-BARRIER DAMAGE

Picchi G.
VALUE OF ANTIRETROVIRAL CNS PENETRATIONEFFECTIVENESS (CPE) 2010 RANKING IN PREDICTING CSF HIV REPLICATION ACCORDING WITH RATE OF VIRAL SUPPRESSION IN PLASMA

Antinori A.
HIV ASSOCIATED NEUROCOGNITIVE DISORDERS: DIFFERENCES IN DIAGNOSTIC TOOLS AND MANAGEMENT STRATEGIES ACROSS ITALIAN HIV CLINICS

Delle Rose D.
THE KINETICS AND MAGNITUDE OF HIV-1 RNA RESPONSES TO ART IN THE CEREBROSPINAL FLUID AND PLASMA OF PATIENTS STARTING THERAPY

16:45 - 18:30
ORAL COMMUNICATIONS - SESSION VI - CLINICAL MEDICINE AND DIAGNOSIS II

Silvestri G.
AIDS Immunology and Immunopathology

Andreoni M.
INTRODUCTION

Nozza S.
APPLICATION OF GENOTYPIC TROPISM TESTING IN CLINICAL PRACTICE: VIROLOGICAL RESPONSE IN MULTIEXPERIENCED HIV-POSITIVE PATIENTS TREATED WITH MARAVIROC-BASED THERAPY.

Canducci F.
EX-VIVO PHENOTYPIC SUSCEPTIBILITY TO GSK-1349572 OF CLONAL VARIANTS SELECTED IN PATIENTS FAILING RALTEGRAVIR

Rossotti R.
RILPIVIRINE IS COMING: HOW WILL IT IMPACT ON HIV-1- INFECTED ITALIAN POPULATION?

Surdo M.
DUAL/MIXED (BUT NOT X4) TROPIC-HIV-1 ISOLATES CAN REPLICATE IN HUMAN PRIMARY MACROPHAGES AND ARE INHIBITED BY CCR5-INHIBITORS

Rusconi S.
PREVALENCE OF ETRAVIRINE (ETR)-RESISTANCE ASSOCIATED MUTATIONS AT NNRTI FAILURE AND PREDICTORS OF RESISTANCE TO ETR IN A LARGE ITALIAN RESISTANCE DATABASE (ARCA)

D'Avolio A.
INTRACELLULAR ACCUMULATION OF RITONAVIR ASSOCIATED WITH DIFFERENT BOOSTED PIS

PASSI-PERDUTI

13:30 - 15:00
SHORT COMMUNICATIONS - SESSION - CLINICAL AND HIV DIAGNOSTIC

Nozza S.
EFFICACY AND SAFETY OF ONCE DAILY MARAVIROC PLUS LOPINAVIR/RITONAVIR IN ANTIRETROVIRAL NAÏVE HIVINFECTED PATIENTS

Lisi L.
MODULATORY EFFECTS OF THE NOVEL CCR5 ANTAGONIST MARAVIROC ON MICROGLIAL PRO INFLAMMATORY ACTIVATION ELICITED BY GP120

Calcagno A.
MONITORING OF VIROLOGICAL AND PHARMACOLOGICAL CEREBROSPINAL FLUID PARAMETERS IN HAART-TREATED HIV-POSITIVE PATIENTS IN THE CLINICAL SETTING

Fabbiani M.
EFFICACY, SAFETY, DISCONTINUATION RATES AND PHARMACOKINETICS OF BOOSTED OR UNBOOSTED ATAZANAVIR WHEN COMBINED WITH A TENOFOVIR OR ABACAVIR CONTAINING BACKBONE

Barbò R.
NEUROIMAGING OF HIV/AIDS PATIENTS TODAY

Parruti G.
ALEXITHYMIA AS A MAJOR CARDIOVASCULAR RISK FACTOR IN HIV-INFECTED PATIENTS

SALA-4

13:30 - 15:00
SHORT COMMUNICATIONS - SESSION - HIV TROPISM AND DNA RESISTANCE

Falasca F.
MONITORING OF DRUG RESISTANCE MUTATIONS IN PROVIRAL DNA OF PATIENTS RESPONDING TO ANTIRETROVIRAL THERAPY

Rozera G.
DYNAMICS AND COMPARTMENTALIZATION OF CXCR4- USING HIV VARIANTS DURING THE EARLY PHASES OF HIV INFECTION, ESTABLISHED BY ULTRA-SENSITIVE NEXT GENERATION SEQUENCING

Cento V.
THE GENOTYPIC FALSE POSITIVE RATE DETERMINED BY POPULATION V3-SEQUENCING CAN PREDICT THE BURDEN OF X4 QUASISPECIES DETECTED BY PYROSEQUENCING

Nozza S.
VIRAL TROPISM BY GENO2PHENO AS A TOOL FOR PREDICTING CD4 DECREASE IN HIV-1 INFECTED NAIVEPATIENTS WITH HIGH CD4 COUNTS

Saracino A.
IMPACT OF MUTATIONS OUTSIDE V3 ON CORECEPTOR TROPISM PHENOTYPICALLY ASSESSED IN SUBTYPE B HIV- 1- INFECTED PATIENTS

Alteri C.
SIGNATURE MUTATIONS IN V3 AND BRIDGING SHEET DOMAIN OF HIV-1 GP120 HIV-1 ARE SPECIFICALLY ASSOCIATED WITH DUAL TROPISM AND MODULATE THE INTERACTION WITH CCR5 N-TERMINUS

Saladini F.
DEVELOPMENT OF RECOMBINANT VIRUS ASSAYS FOR PHENOTYPIC EVALUATION OF THE SUSCEPTIBILITY TO INTEGRASE INHIBITORS AND HIV CORECEPTOR TROPISM

SALA-ONICE

13:30 - 15:00
SHORT COMMUNICATIONS - SESSION - PREVENTION AND SOCIAL ASPECTS

Porcari F.
HIVOICES

Rossotti R.
GAY SEX ON THE WEB IN MILAN: SOCIAL NEEDS AND RISKY BEHAVIORS

Dal Conte I.
THE GIOCASICURO PROJECT: RESULTS OF A COMPREHENSIVE INTERVENTION FOR THE PREVENTION AND DIAGNOSIS OF SEXUALLY TRANSMITTED INFECTIONS AMONG MEN WHO HAVE SEX WITH MEN IN ITALY

Cosmaro M.L.
FACILITATED ACCESS PROCEDURES FOR HIV AND HCV TESTING IN VULNERABLE GROUPS

Lichtner M.
TEST DAY IN THE ERA OF "SEEK, TEST AND TREAT" FOR HIV

Tavio M.
ACUTE CASE DEFINITION FOR BEDSIDE DIAGNOSIS OF SUSPECTED/PROBABLE HIV-1 INFECTION IN THE COMMUNITY SETTING

Lai A.
HIGH PROPORTION OF HIV-1 SUBTYPE F1 TRANSMISSION NETWORKS AMONG ITALIAN HETEROSEXUAL MALES ASSOCIATED WITH INTRODUCTION EVENTS FROM SOUTH AMERICA

SALA-VERDE

09:45 - 11:30
ORAL COMMUNICATIONS - SESSION II - EPIDEMIOLOGY AND PREVENTION

Suligoi B.
INTRODUCTION

Breveglieri M.
SIALON PROJECT (2008-2010): HIV PREVALENCE, UNDIAGNOSED INFECTIONS, DRUG USE AND UNPROTECTED ANAL INTERCOURSE AMONG MSM ATTENDING GAY VENUES IN SIX EUROPEAN CITIES (BARCELONA, BRATISLAVA, BUCHAREST, LJUBLJANA, PRAGUE AND VERONA)

Rancilio L.
2007-2010: DAY CARE ACCOMODATION FOR PLWHA IN LOMBARDY REGION

Ammassari A.
IN A HAART NON-ADHERENT POPULATION, WOMEN REPORT SIGNIFICANTLY POORER ADHERENCE BEHAVIORS, HIGHER SYMTPOMS RATES, AND WORSE HEALTH STATUS WHEN COMPARED TO MEN

Colucci A.
ACCESS TO HIV TESTING IN ITALY

D'Amato S.
HIV INFECTION AND MIGRANTS: A PILOT STUDY BASED ON THE EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL (ECDC) INDICATORS

Puro V.
HIV POST-EXPOSURE PROPHYLAXIS IN ITALY (1996-2009)

12:00 - 13:45
ORAL COMMUNICATIONS - SESSION IV - CLINICAL IMMUNOLOGY

Tambussi G.
INTRODUCTION

Bandera A.
CMV-SPECIFIC INTERLEUKIN-17-PRODUCING CD4+ T CELLS (TH17) ARE EXPANDED IN HIV-INFECTED PATIENTS LACKING IMMUNOLOGICAL RECOVERY DESPITE EFFECTIVE ANTIRETROVIRAL TREATMENT

Bellistrì G.M.
INCREASED BONE MARROW INTERLEUKIN-7 (IL7)/IL 7R BUT REDUCED IL-7 RESPONSIVENESS IN HIV INFECTED PATIENTS LACKING CD4+ GAIN ON ANTIVIRAL THERAPY

Buonomini A.R.
EXPANSION OF ACTIVATED T LYMPHOCYTES (CD3+CD4+HLADR+ AND CD3+CD8+HLADR+) IN PATIENTS TREATED WITH HAART WITH VIRAL BLIPS OR LOW LEVELS OF RESIDUAL VIREMIA

Rusconi S.
IMMUNOLOGICAL EFFICACY OF MARAVIROC (MVC) AS INTENSIFICATION STRATEGY IN HIV-INFECTED PATIENTS (PTS) FAILING CD4 RECOVERY ON VIROLOGICALLY-SUPPRESSIVE HAART

Borderi M.
FIRST DEMONSTRATION OF A DIRECT VIRAL DAMAGE ON HUMAN VESSEL WALL DERIVED MESENCHYMAL STEM CELLS BIOLOGIC HOMEOSTASIS: A NEW ROLE OF HIV-1 INFECTION AND RECOMBINANT GP120 IN THE GENESIS OF ATHEROSCLEROTIC DEGENERATION AND ADIPOGENESIS INDUCTION

15:00 - 16:30
SYMPOSIUM - ANTIRETROVIRAL DRUGS MONITORING

Di Perri G.
INTRODUCTION

Boffito M.
NEW CHALLENGES IN MANAGEMENT OF DRUG INTERACTIONS

Hill A.
DOSE-OPTIMISATION OF ANTIRETROVIRAL

Maserati R.
PHARMACOKINETIC REQUIREMENTS IN DIFFERENT THERAPEUTICAL CIRCUMSTANCES

Bonora S.

16:45 - 18:30
ORAL COMMUNICATIONS - SESSION VII - CLINICAL EPIDEMIOLOGY

D'Arminio Monforte A.
INTRODUCTION

Scognamiglio P.
FINAL RESULTS OF AN OUTREACH PROGRAM OF HIV RAPID TESTING AMONG MARGINALIZED PEOPLE LIVING IN ROME, ITALY

Giuliani M.
INCREASING TREND IN HIV-1 INCIDENCE AMONG MEN WHO HAVE SEX WITH MEN IN ROME, ITALY

Dorrucci M.
CHANGES IN SURVIVAL OF HIV-SEROCONVERTED PATIENTS ENROLLED IN THE IHS STUDY FROM 1985 TO 2007

Massimiliani E.
HIV SURVEILLANCE SYSTEM AND LATE PRESENTERS IN EMILIA-ROMAGNA, 2006-2009

Ammassari A.
HEALTH-CARE DELIVERY CHARACTERISTICS OF CLINICAL CENTERS ARE CORRELATED WITH SURVIVAL OF ITALIAN HIV PATIENTS

Viganò A.
SINGLE AND DOUBLE DOSES OF 2009 PANDEMIC INFLUENZA A H1N1 VACCINE ARE EQUALLY IMMUNOGENIC IN HIV-INFECTED ADOLESCENTS AND YOUNG ADULTS

29/03/11

AUDITORIUM

08:30 - 09:45
LECTURES

Galli M.
HIV/AIDS IN DEVELOPED COUNTRIES: CLINICAL ASPECTS AND COMORBIDITIES

Pozniak A.
ANTIVIRAL THERAPY-PRESCRIPTIVE OR PROACTIVE?

09:45 - 11:15
ORAL COMMUNICATIONS - SESSION VIII - CLINICAL AND ANTIRETROVIRAL THERAPY I

Castagna A.
Introduction

Lazzarin A.
ARTEMIS: 192-WEEK EFFICACY AND SAFETY OF ONCEDAILY DARUNAVIR/RITONAVIR (DRV/R) VS LOPINAVIR/R (LPV/R) IN TREATMENT-NAÏVE HIV-1- INFECTED ADULTS

Giambenedetto Di
TREATMENT SIMPLIFICATION TO ATAZANAVIR/RITONAVIR PLUS LAMIVUDINE QD IN PATIENTS ON TWO NRTIS PLUS ATAZANAVIR/RITONAVIR WITH OPTIMAL VIROLOGIC CONTROL: 48 WEEKS SAFETY AND EFFICACY RESULTS FROM A PILOT STUDY (ATAZANAVIR AND LAMIVUDINE SIMPLIFICATION STUDY)

Trotta M.P.
WITH CURRENT ARV TREATMENTS VIROLOGICAL FAILURE MOSTLY OCCURS IN THE CONTEXT OF OPTIMAL SELF-REPORTED ADHERENCE

Lo Caputo S.
DID THE CHANGE OVER TIME IN HIV TREATMENT GUIDELINES AFFECT THE PROBABILITY OF ART INITIATION AT DIFFERENT LEVELS OF CURRENT CD4 COUNT? EVIDENCE FROM A COHORT OF HIV PATIENTS ENROLLED IN ITALY WHEN THEIR CD4 COUNT WAS >500 CELLS/MM3

Sagnelli C.
FACTORS INFLUENCING LIVER FIBROSIS AND NECROINFLAMMATION IN HIV/HCV COINFECTION AND HCV MONOINFECTION

De Re V.
ASSOCIATION OF KIR/HLA-LIGAND COMBINATIONS WITH DIFFERENT HCV/HIV-RELATED DISORDERS

11:30 - 13:00
ROUND TABLE - ACCESS SUSTENIBILITY OF ANTIRETROVIRAL THERAPY

Carosi G.
Introduzione

Scaramuccia D.

Rizzardini G.

Del Santo. A.

14:30 - 15:00
LECTURE

Pantaleo G.
IMMUNOLOGIC RESPONSE

15:00 - 16:15
SYMPOSIUM - IMMUNOGENETICS OF HIV: MODULATION OF RESISTANCE AND SUSCEPTIBILITY TO INFECTION

Clerici M.
INTRODUCTION

Giacca M.
UNSPECTED MOLECULAR PARTNER FOR THE HIV-1 TAT PROTEIN

Tarr P.
GENETICS SCREENING FOR HIV-RELATED COMPLICATIONS AS A CLINICALLY RELEVANT PREDICTION TOOL

Cossarizza A.
MITOCHONDRIA GENOMICS: AN UPDATE

Lopalco L.
NATURAL REGULATORS OF CCR5 INTERNALIZATION AND IMPLICATION FOR VACCINE AND THERAPEUTICS AGAINST HIV INFECTION

Miyazawa M.
HIG-LEVEL RAC2 EXPRESSION ASSOCIATED WITH NOVEL INTRON POLYMORPHISMS RESTRICTS HIV-1 REPLICATION IN EXPOSED SENONEGATIVE INDIVIDUALS

16:15 - 17:45
ROUNDE TABLE - OPEN QUESTIONS IN HIV MANAGEMENT AND HIGHLIGHTS FROM ICAR 2011

2012 ICAR

De Luca A.

Ammassari A.

Cinque P.

Mussini C.

17:45 - 18:15
ICAR 2011 AWARDS

SIMIT Premio

18:15 - 18:30
FINAL REMARKS

Mazzotta F.

The Congress Queen

PASSI-PERDUTI

13:00 - 14:30
SHORT COMMUNICATIONS - SESSION - COMPLICATION OF HIV INFECTION AND ANTIRETROVIRAL THERAPY

Sabbatini F.
IMPACT OF RENAL IMPAIRMENT AND COMBINED ANTIRETROVIRAL TREATMENT ON ARTERIAL STRUCTURE AND STIFFNESS

Orlando G.
EAT VOLUME IS AN INDEPENDENT RISK FACTOR OF CARDIOVASCULAR DISEASE IN HIV-INFECTED PATIENTS

D'Abramo A.
OSTEOPROTEGERIN AS A BIOMARKER OF SUBCLINICAL ATHEROSCLEROSIS IN HIV-INFECTED MAN

Schiaroli E.
LEFLUNOMIDE PROTECTS AGAINST DYSLIPIDEMIA DEVELOPMENT INDUCED BY RITONAVIR IN MICE Scheda Relatore

Merlini E.
MICROBIAL TRANSLOCATION (MT)-INDUCED IMMUNE ACTIVATION ASSOCIATES TO ATHEROSCLEROSIS IN CART TREATED HIV POS PATIENTS

Belfiori B.
CIRCULATING MARKERS OF ENDOTHELIAL DISFUNCTION, FLOW-MEDIATED VASODILATION AND CIRCULATING ENDOTHELIAL CELLS IN HIV INFECTION: EFFECT OF ABACAVIR VERSUS TENOFOVIR

Focà E.
BONE TURN-OVER MARKERS IN HIV POSITIVE PATIENTS AFTER HAART: TENOFOVIR (TDF) + EMTRICITABINE (FTC) + ATAZANAVIR/RITONAVIR (ATV/R) ?VS- TDF + FTC + EFAVIRENZ (EFV). RESULTS OF INCA TRIAL

SALA-ONICE

13:00 - 14:30
SHORT COMMUNICATIONS - SESSION - HIV CLINICAL DIAGNOSTIC

Nasta P.
SUSTAINED VIROLOGICAL RESPONSE (SVR) TO ANTIHEPATITIS C (HCV) THERAPY IS ASSOCIATED WITH A SIGNIFICANT INCREASE OF TRIGLYCERIDE (TGD) AND TOTAL CHOLESTEROL (TC) PLASMA LEVELS

Sagnelli C.
LIVER STEATOSIS IN HIV/HCV COINFECTED AND HCV-MONOINFECTED PATIENTS: AN HISTOLOGICAL COMPARISON

Zanini F.
MULTI DRUG RESISTANT TUBERCULOSIS AND HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN THE URBAN SETTING OF MILAN (1996-2009): AN AKWARD HERITAGE OF THE RECENT PAST Scheda Relatore

Antonucci G.
CHARACTERISTICS OF ANTI-HBV TREATMENT IN A COHORT OF ITALIAN HBV-INFECTED PATIENTS IN RELATION TO HIV-INFECTION STATUS

Apostoli A.
INCIDENCE OF C.TRACHOMATIS GENITAL INFECTIONS IN A COHORT OF HIV INFECTED WOMEN

Marocco R.
PORPHYRIA CUTANEA TARDA IN TWO ARV-SUPPRESSED PATIENTS WITH HIV/HCV COINFECTION

De Socio G.V.
MALIGNANT SYPHILIS CONFIRMED IN SKIN BIOPSY BY IMMUNOHISTOCHEMICAL STAINING IN AN HIV-INFECTED PATIENT

SALA-VERDE

09:45 - 11:15
ORAL COMMUNICATIONS - SESSION IX - CLINICAL AND ANTIRETROVIRAL THERAPY II

Borderi M.
Introduction

Misciagna D.
HIGHER EXPRESSION OF ADIPONECTIN Q AND LOWER EXPRESSION OF ENHANCER BINDING PROTEIN ALPHA IN ADIPOSE TISSUE CHARACTERIZE HIV-1 INFECTED PATIENTS WITH LIPODYSTROPHY

Pocaterra D.
TDF THERAPY IS INDEPENDENTLY ASSOCIATED TO HYPERPARATHYROIDISM IN A SAMPLE OF 371 HIV INFECTED PATIENTS

Madeddu G.
IS THERE A RELATION BETWEEN MYALGIA AND CENTRAL NERVOUS SYSTEM SYMPTOMS IN PATIENTS RECEIVING RALTEGRAVIR? RESULTS FROM THE SCOLTA PROJECT.

Franzetti M.
INCIDENCE TRENDS AND OUTCOME OF NON-AIDSDEFINING MALIGNANCIES (NADM) IN A COHORT OF HIVINFECTED PATIENTS DURING THE PERIOD 1985-2008

Guida M.G.
HAART IS EFFECTIVE TO PREVENT CERVICO-VAGINAL CYTOLOGICAL ABNORMALITIES RELATED TO HPV HIGHLY ONCOGENIC STRAINS

Dal Conte I.
PREVALENCE OF HPV SUBTYPES AND ANAL DISPLASIA AMONG A GROUP OF HIV-POSITIVE PEOPLE WITH ANAL COMPLAINS